Attorneys Note Possible UK Metal-on-Metal Hip Ban
According to resources, metal-on-metal hip implants such as those marketed and manufactured by DePuy could be banned in the UK after analysis of over 17,000 cases concludes unacceptably high failure rates. The proposed ban, which would affect facilities in the UK’s National Health Service (NHS), follows a review by the country’s National Institute for Health & Care Excellence (NICE) that established failure rates as high as 43 percent for some of the devices.
If you or a loved one have been fitted with a DePuy hip implant and suffered from complications such as pain, inflammation or you required revision surgery or if you have questions about the UK metal-on-metal hip ban, contact an experienced attorney to learn more. You may be entitled to seek compensation for your injuries.
UK Metal-on-Metal Hip Ban
The NICE recommended that NHS hospitals cease using implants with failure rates higher than 5 percent, which would remove virtually every metal-on-metal device from the health system. According to one article, two metal-on-metal hip implants just barely met the requirement to remain in use.
The UK metal-on-metal hip ban follows the high-profile August 2010 recall of DePuy Orthopaedics’ ASR hip and ASR XL acetabular resurfacing systems. Its manufacturer, Johnson & Johnson, removed the devices from the market after receiving reports that a higher-than-normal number of patients required revision surgeries to remove or correct defective implants.
Additionally, some reports warned that hundreds of thousands of patients may have also been exposed to toxic materials from these devices, placing them at an increased risk of developing cardiomyopathy, cancer, changes to DNA and muscle or bone destruction. Since then, the controversy has spread to include other device makers and personal injury lawsuits against devices that have not yet been recalled.
Effects of the UK Metal-on-Metal Hip Ban
While the NICE audit found that the DePuy ASR device posted a failure rate of 43 percent after nine years and noted high failure rates for metal-on-metal hip resurfacing implants, it remains to be seen the effect that this conclusion will have in the U.S., particularly since the device has already been recalled and lawsuits against the manufacturer are currently pending.
While some question about whether the UK metal-on-metal hip ban goes far enough, many overseas feel that it is a step in the right direction as most hip implants will be removed from hospitals, similar to the current recall in place in the U.S. Additionally, plaintiffs continue to file lawsuits in the U.S. against the manufacturers of the devices in an attempt to seek compensation for their injuries.
Side effects include:
- Metal sensitivity
- Bone fracture
- Soft tissue damage
- Difficulty walking
The DePuy ASR hip implant was recalled in the U.S. in August 2010 due to high failure rates and increased risk of complications. The recall removed over 93,000 ASR hip implants from the market, and data from a British national joint registry showed, at that time, that 12 percent of patients with the implant required a revision or corrective surgery within five years of implantation. Currently, however, that number has increased to 43 percent, according to information supplied alongside the UK metal-on-metal hip ban.
Want to Learn More about DePuy and the UK Metal-on-Metal Hip Ban?
If you or someone you love has suffered from injuries or complications such as difficulty walking, metallosis, inflammation or pain after implantation with a DePuy device, contact the American Injury Attorney Group today. We will review your case, answer your questions and concerns and determine if you have a valid claim. We will connect you with an experienced DePuy lawsuit attorney to help you receive compensation. You may be eligible to file for damages for medical bills, pain and suffering and lost wages.FREE Case Evaluation